| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/07/2002 | US20020028519 Preferential detection of particle in sample; obtain sample, expose to light source, detect scattered light with eye, visibily scattered light indicates preferential particles in sample |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028513 P element derived vector and methods for its use |
| 03/07/2002 | US20020028512 Auxin sensitizer |
| 03/07/2002 | US20020028502 Device for sizing nucleic acids, proteins or peptide nucleic acids |
| 03/07/2002 | US20020028498 Genetically engineered nucleotide sequences for use in the treatment of viral disease and tumors |
| 03/07/2002 | US20020028497 Method for producing recombinant adenovirus |
| 03/07/2002 | US20020028495 Deoxyribonuclease II beta proteins and cDNAs |
| 03/07/2002 | US20020028494 57256 and 58289, novel human transporters and uses thereof |
| 03/07/2002 | US20020028492 Adjusting aliphatic and aromatic hydrocarbon in bacteria; incubate impure sample and bacteria, monitor sample for reduction in hydrocarbon impurities |
| 03/07/2002 | US20020028488 Transgenic avian species for making human and chimeric antibodies |
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028483 Novel potassium channel molecules and uses therefor |
| 03/07/2002 | US20020028482 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of autoimune disease, arthritis, infections, myasthenia gravis, asthma and cancer |
| 03/07/2002 | US20020028481 Expression using fused genes providing for protein product |
| 03/07/2002 | US20020028465 Genetic engineering; anticancer agents |
| 03/07/2002 | US20020028462 Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's disease |
| 03/07/2002 | US20020028459 Two-step hybridization and capture of a polynucleotide |
| 03/07/2002 | US20020028458 Amplifying signal associated with preferential nucleotide sequences; obtain nucleotide sequences, label, ligate target nucleotide sequences and adaptor molecule, amplify, recover sequences |
| 03/07/2002 | US20020028452 Measuring amount of nucleotide sequences in sample; obtain sample, ampify nucleotide sequences, determine initial concentration of the nucleic acid in sample |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028448 Evaluating modulators of transcription; obtain modulator, incubate with test protein, monitor modulators binding activity, monitor for adjustment in transcriptional activation and protein expression |
| 03/07/2002 | US20020028447 cDNA synthesis improvements |
| 03/07/2002 | US20020028446 System and method for molecule selection using extended target shape |
| 03/07/2002 | US20020028444 Method and kits for preparing multicomponent nucleic acid constructs |
| 03/07/2002 | US20020028443 Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028433 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/07/2002 | US20020028219 Novel liposome complexes for increased systemic delivery |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 03/07/2002 | US20020028211 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028202 Common gamma chain blocking agents |
| 03/07/2002 | US20020028194 DNA encoding a transcription unit comprising a transgene linked to expression control sequences, a an adenovirus E3 region, and a modified E4 region containing E4ORF3, and at least one other portion of an adenovirus E4 region |
| 03/07/2002 | US20020028193 Host cell transfected by a vector comprising a DNA sequence encoding a beta 2AR operably linked to a promoter that is functional in said cell. |
| 03/07/2002 | DE10123071A1 Neue für das ccpA2-Gen kodierende Nukleotidsequenzen New coding for the ccpA2 gene nucleotide sequences |
| 03/07/2002 | DE10042051A1 Neue für das cstA-Gen kodierende Nukleotidsequenzen New coding for the cstA gene nucleotide sequences |
| 03/07/2002 | DE10041238A1 Verfahren zur Identifizierung spezifisch spaltbarer peptide und Verwendung solcher Peptidsequenzen A method for identifying specific cleavable peptide and use of such peptide sequences |
| 03/07/2002 | DE10038722A1 Verfahren zur Reduzierung von spezifischen Immunreaktionen A process for the reduction of specific immune responses |
| 03/07/2002 | CA2705366A1 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 03/07/2002 | CA2457165A1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421122A1 Novel nucleic acids and polypeptides |
| 03/07/2002 | CA2421088A1 Novel polypeptide |
| 03/07/2002 | CA2421078A1 Method for determining alleles |
| 03/07/2002 | CA2421063A1 Methods for stable transduction of cells with viral vectors |
| 03/07/2002 | CA2420902A1 18 human secreted proteins |
| 03/07/2002 | CA2420900A1 Thrombomodulin analogs for use in recovery of signal cord injury |
| 03/07/2002 | CA2420879A1 Anti-microbial agents |
| 03/07/2002 | CA2420877A1 Isomaltulose synthase |
| 03/07/2002 | CA2420876A1 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | CA2420867A1 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | CA2420856A1 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | CA2420855A1 Improvements in and relating to marking using dna |
| 03/07/2002 | CA2420845A1 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/07/2002 | CA2420840A1 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/07/2002 | CA2420724A1 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/07/2002 | CA2420696A1 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420374A1 Process for production of biopterin compound |
| 03/07/2002 | CA2420276A1 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420103A1 Modulation of fas and fasl expression |
| 03/07/2002 | CA2420062A1 Erbb4 antagonists |
| 03/07/2002 | CA2419860A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | CA2419661A1 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | CA2419613A1 Methods for reducing complexity of nucleic acid samples |
| 03/07/2002 | CA2419578A1 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | CA2419480A1 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/07/2002 | CA2419275A1 Butinol i esterase |
| 03/07/2002 | CA2419251A1 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | CA2419152A1 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 03/07/2002 | CA2418502A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/07/2002 | CA2417261A1 Carotenoid production from a single carbon substrate |
| 03/07/2002 | CA2417233A1 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | CA2389579A1 Method for obtaining a surface activation of a solid support for building biochips microarrays |
| 03/06/2002 | EP1184665A1 Method for measuring protein kinase activity |
| 03/06/2002 | EP1184468A2 Method for sequencing using probe arrays |
| 03/06/2002 | EP1184467A2 Screening method for gene variation |
| 03/06/2002 | EP1184466A2 Target nucleic acid enrichment and amplification for array analysis |
| 03/06/2002 | EP1184465A2 Method for diagnosing polymorphisms in human MCT-1 and drugs related to such polymorphisms |
| 03/06/2002 | EP1184463A1 Method of detecting protein-protein interaction |
| 03/06/2002 | EP1184462A2 Identification of targets of antimicrobial compounds |
| 03/06/2002 | EP1184461A2 Creation of gene targeting vectors using homologous recombination in yeast |
| 03/06/2002 | EP1184460A1 Modified fungal xylanases |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1184458A1 Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof |
| 03/06/2002 | EP1184457A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/06/2002 | EP1184456A2 Haplotypes of the AGTR1 gene |
| 03/06/2002 | EP1184455A1 Method for predicting binding site structure of gene regulator and apparatus therefor |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1184391A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184390A2 Acetylcholine receptor subunits |